USFDA completes audit at Dr. Reddy’s API Cuernavaca plant in Mexico

21 Jul 2017 Evaluate

US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ API Cuernavaca plant at Mexico with Zero observation.

Earlier, USFDA completed audit of the company’s Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, on June 16, 2017. The pharma major had been issued a Form 483 with one observation, which it is addressing.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

 

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×